Yanli F. Jin

601 West Huangpu Blvd
Guangzhou, 510632, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Enantioselective synthesis of chiral 1,2-oxazinane spiro-oxindoles via carbene-catalyzed [3 + 3] annulation of isatin-derived nitrones with enals.

Enantioselective synthesis of chiral 1,2-oxazinane spiro-oxindoles via carbene-catalyzed [3 + 3] annulation of isatin-derived nitrones with enals.

Journal: Organic & biomolecular chemistry
Published: May 26, 2026

Effects of solamargine in hepatic metastasis of colorectal cancer: induction of ferroptosis and elimination of cancer stem cells.

Effects of solamargine in hepatic metastasis of colorectal cancer: induction of ferroptosis and elimination of cancer stem cells.

Journal: Chinese medicine
Published: April 23, 2025

Phages in human health and gut microbiota transplantation therapy

Phages in human health and gut microbiota transplantation therapy

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: March 24, 2025

The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis.

The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis.

Journal: The Journal of biological chemistry
Published: December 17, 2024

Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by blocking NT5DC2 mRNA translation.

Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by blocking NT5DC2 mRNA translation.

Journal: Oncogene
Published: July 26, 2024

SMYD3 Activates Fatty Acid β-Oxidation to Promote Self-Renewal of Leukemia Stem Cells.

SMYD3 Activates Fatty Acid β-Oxidation to Promote Self-Renewal of Leukemia Stem Cells.

Journal: Cancer research
Published: June 24, 2024

Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.

Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.

Journal: Molecular cancer
Published: April 19, 2024

PRMT1 Promotes the Self-renewal of Leukemia Stem Cells by Regulating Protein Synthesis.

PRMT1 Promotes the Self-renewal of Leukemia Stem Cells by Regulating Protein Synthesis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 09, 2023

Protocol for isolation and analysis of the leukemia stem cells in BCR-ABL-driven chronic myelogenous leukemia mice.

Protocol for isolation and analysis of the leukemia stem cells in BCR-ABL-driven chronic myelogenous leukemia mice.

Journal: STAR protocols
Published: September 19, 2022

Correction to: Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl.

Correction to: Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl.

Journal: Molecular cancer
Published: December 31, 2021

Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin.

Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin.

Journal: Molecular cancer
Published: October 23, 2021

Super-enhancer landscape reveals leukemia stem cell reliance on X-box binding protein 1 as a therapeutic vulnerability.

Super-enhancer landscape reveals leukemia stem cell reliance on X-box binding protein 1 as a therapeutic vulnerability.

Journal: Science translational medicine
Published: September 22, 2021
Showing 1-12 of 30

Last Updated: 09/26/2026